Accueil>>Signaling Pathways>> Microbiology & Virology>> Parasite>>Halofantrine hydrochloride (SKF-102886)

Halofantrine hydrochloride (SKF-102886) (Synonyms: (±)-Halofantrine, SKF 102886, WR 171669)

Catalog No.GC32377

Le chlorhydrate d'halofantrine (SKF-102886) (SKF-102886) est un bloqueur du courant potassique redresseur retardé via l'inhibition du canal HERG (human-ether-a-go-go-related gene) et un puissant composé antipaludéen.

Products are for research use only. Not for human use. We do not sell to patients.

Halofantrine hydrochloride (SKF-102886) Chemical Structure

Cas No.: 36167-63-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
141,00 $US
En stock
1mg
43,00 $US
En stock
5mg
119,00 $US
En stock
10mg
211,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound[1][2].

[1]. Krishna S, et al. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. Br J Clin Pharmacol. 1993 Dec;36(6):585-91. [2]. Tie, H., et al., Inhibition of HERG potassium channels by the antimalarial agent halofantrine. Br. J. Pharmacol. 130, 1967-1975, (2000) Traebert.

Avis

Review for Halofantrine hydrochloride (SKF-102886)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Halofantrine hydrochloride (SKF-102886)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.